Clinical and regulatory pathways.
Clinical trial approvals, ethics committees, DCGI/Central Licensing, device registration, and lifecycle regulatory strategy.
Clinical & regulatory
Quality & pharmacovigilance
Healthcare provider strategy
Digital health & data
M&A & partnerships
Scroll
Sector Dynamics
Legal Imperative
Healthcare pioneers balance cutting-edge science with intense statutory oversight as they advance clinical research, digital therapeutics, and precision manufacturing. CDSCO fast-tracks, data privacy norms, and pricing controls require harmonised compliance between hospitals, labs, CROs, and medtech partners. Global investors expect pharmacovigilance evidence, GMP resilience, and ethical marketing governance embedded from boardroom to bedside. Lapses in consent management, supply serialization, or telehealth protocols can derail approvals and erode patient trust. We choreograph regulatory foresight, quality documentation, and crisis drills so health enterprises scale safely and sustainably.
CELA & Industry
CELA & Therapeutic Integrity
We advise hospitals, med-tech, diagnostics, pharmaceuticals, nutraceuticals, and digital health platforms on end-to-end business models. From R&D to commercialisation, we provide regulatory strategy, operational policies, and deal execution that withstand domestic and international scrutiny.
Our Core Capabilities
How CELA Supports Healthcare & Life Sciences
Quality, safety, and growth frameworks anchored in robust compliance.
Manufacturing & quality systems.
GMP/GDP alignment, quality agreements, pharmacovigilance, tech transfers, and supply chain diligence across geographies.
Healthcare operations & risk.
Hospital governance, clinical protocols, telemedicine compliance, insurance partnerships, and incident response.
Digital health & data ethics.
DPDP, HIPAA-equivalent controls, consent, EHR interoperability, AI/ML governance, and cybersecurity playbooks.
Market access & pricing.
NPPA price controls, tender strategy, patient support programmes, marketing compliance, and KOL engagement frameworks.
Strategic transactions.
Joint ventures, licensing, contract manufacturing, M&A, and cross-border collaborations with IP and regulatory alignment.
We balance patient safety, regulatory integrity, and investor-grade governance so that care innovations thrive.
Industry Focus
Services for Healthcare, Life Sciences & Pharma:
Regulatory Strategy
Learn More
Clinical Trials & Approvals
Prepare applications, site agreements, ethics documentation, and compliance monitoring for clinical trials and device studies.
Operational Excellence
Learn More
Hospital & Provider Governance
NABH readiness, clinical governance manuals, telehealth policies, and risk management protocols.
Quality & Supply
Learn More
Manufacturing & PV Systems
Draft quality agreements, manage pharmacovigilance, and secure supply chain continuity across geographies.
Digital Health
Learn More
Data, AI & Telemedicine
Construct privacy frameworks, AI governance, cross-border data flows, and secure digital care delivery.
Market Access
Learn More
Pricing, Market Entry & PSPs
Navigate NPPA price caps, tender bids, managed access programmes, and patient support initiatives responsibly.
Strategic Deals
Learn More
Licensing, JV & M&A
Execute licensing, co-development, contract manufacturing, and cross-border M&A with diligence and integration support.
Client Impact Spotlight
Our Clients’ Success in Agriculture, Food & FMCG/CPG
Explore More
Link care innovation with digital, capital, and infrastructure allies.
Accelerate health outcomes by pairing clinical precision with venture-backed med-tech, trusted data infrastructure, and resilient real estate ecosystems.
Integrated health intelligence for bold builders
See how life sciences leaders orchestrate R&D, market entry, and patient experience while staying audit-ready globally.